ARCHIVES

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

President’s Cancer Panel Urges Greater Emphasis On Prevention.

September 21, 2007

NCI To Cut Smoking Intervention Study By 20%, Says Chemoprevention Accrual Has Priority

November 6, 1992

In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’

July 27, 1990

NIH Advisors Urge Stronger Peer Review, Clinical Center Renewal

May 20, 1994

DCPC Board Approves Nine Concepts, New Small Cancer Control Grants, Rerelease Of FDA For Nutrition Core Grants

January 20, 1984

NCI Considers Seeking New Study Section For Clinical Research, Or Expansion Of E2

November 23, 1990